| Company Name: | Vascular Solutions Incorporated | | Ticker Symbol: | VASC | | | WWW Address: | www.vascularsolutions.com | | CEO: | Howard Root | | No. of Employees: | 252 | | Common Issue Type: | CS | | Business Description: | A medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 8.43 |  0.04 | 7.71 | 9.25 | 8.4 | 8.50 | 8.40 | 20082 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 138.3 | 16.4 | 0.56 | 1.01 | 0.00 | 7.3 | 0.0 | 9.80 - 5.04 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 8.43 | $ | | PE Ratio - LTM | 7.3 | |
| Market Capitalisation | 138.2 | mil |
| Latest Shares Outstanding | 16.4 | mil |
| Earnings pS (EPS) | 1.01 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 242,940 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 15.7 | mil |
| Float as % of Shares Outstanding | 96.0 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 45.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 11.20 | % |
| Gross Profit Margin | 67.5 | % |
| EBITDA Margin | 11.0 | % |
| Pre-Tax Profit Margin | 11.1 | % |
| Assets Turnover | 1.7 | % |
| Return on Assets (ROA) | 37.3 | % |
| Return on Equity (ROE) | 49.0 | % |
| Return on Capital Invested (ROCI) | 49.0 | % |
| Current Ratio | 5.3 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 191.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 1.82 | $ |
| Cash pS | 0.86 | $ |
| Book-Value pS | 2.30 | $ |
| Tangible Book-Value pS | 2.29 | $ |
| Cash Flow pS | 1.21 | $ |
| Free Cash Flow pS | 0.42 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.67 | |
| Price/Tangible Book Ratio | 3.69 | |
| Price/Cash Flow | 7.0 | |
| Price/Free Cash Flow | 20.3 | |
| P/E as % of Industry Group | 25.0 | % |
| P/E as % of Sector Segment | 14.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 4.3 | 103 | 424 | 873 |
| 4 Weeks | 8.50 | 7.60 | 7.72 | 9.2 | 102 | 412 | 7,423 |
| 13 Weeks | 9.80 | 7.41 | 7.87 | 7.1 | 99 | 557 | 34,529 |
| 26 Weeks | 9.80 | 6.76 | 7.00 | 20.4 | 100 | 694 | 87,447 |
| 52 Weeks | 9.80 | 5.04 | 7.22 | 16.8 | 94 | 615 | 153,642 |
| YTD | 9.80 | 5.04 | - | -6.5 | 76 | 607 | 138,380 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 8.26 | 8.19 | 8.17 | 7.82 | 7.41 | 0.56 | 0.43 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 25.00 | 95.2 | 15.13 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 20.77 | NA | -11.09 |
| R&D | 16.24 | NA | 17.98 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 12.0 | 11.4 | 15.8 |
| Earnings % | 152.2 | -16.9 | 0.0 |
| EPS % | 155.6 | -18.2 | 0.0 |
| EPS $ | 0.14 | -0.02 | 1.29 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 51.33 |
| Current Ratio | 4.3 |
| Quick Ratio (Acid Test) | 2.3 |
| Liquidity Ratio (Cash) | 1.04 |
| Receivables Turnover | 7.6 |
| Average Collection Period | 47 |
| Working Capital/Equity | 71.3 |
| Working Capital pS | 1.41 |
| Cash-Flow pS | 1.10 |
| Free Cash-Flow pS | -0.24 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 9.48 |
| Financial Leverage Ratio (Assets/Equity) | 1.4 |
| Debt Ratio | 28.0 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 17.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 51.5 |
| Interest/Capital Invested | 0.17 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 2.79 |
| Tobin's Q Ratio | 3.13 |
| Current P/E Ratio - LTM | 7.30 |
| Enterprise Value (EV)/EBITDA | 31.97 |
| Enterprise Value (EV)/Free Cash Flow | -50.29 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.69 |
| Price/Book Ratio - LTM | 3.67 |
| Price/Cash Flow Ratio | 7.0 |
| Price/Free Cash Flow Ratio - LTM | 20.3 |
| Price/Sales Ratio | 2.07 |
| P/E Ratio (1 month ago) - LTM | 6.8 |
| P/E Ratio (26 weeks ago) - LTM | 6.6 |
| P/E Ratio (52 weeks ago) - LTM | 55.5 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 25.0 |
| P/E as % of Sector Segment | 14.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 7.9 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.43 |
| Tangible Book Value pS - LTM | 2.29 |
| Book Value pS - LTM | 2.30 |
| Capital Invested pS | 1.94 |
| Cash pS - LTM | 0.86 |
| Cash Flow pS - LTM | 1.21 |
| Free Cash Flow pS - LTM | 0.42 |
| Earnings pS (EPS) | 1.01 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -6.24 |
| Free Cash Flow Margin 5YEAR AVG | -7.25 |
| Net Profit Margin | 26.4 |
| Net Profit Margin - 5YEAR AVRG. | 2.8 |
| Equity Productivity | 1.92 |
| Return on Equity (ROE) | 50.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 6.9 |
| Capital Invested Productivity | 1.92 |
| Return on Capital Invested (ROCI) | 50.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 6.8 |
| Assets Productivity | 1.60 |
| Return on Assets (ROA) | 36.6 |
| Return on Assets (ROA) - 5YEAR AVRG. | 4.5 |
| Gross Profit Margin | 67.5 |
| Gross Profit Margin - 5YEAR AVRG. | 70.0 |
| EBITDA Margin - LTM | 11.0 |
| EBIT Margin - LTM | 11.2 |
| Pre-Tax Profit Margin | 5.1 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -3.2 |
| Effective Tax Rate | -417.0 |
| Effective Tax Rate - 5YEAR AVRG. | -84.8 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 216 |
| Revenue per Employee | 242,940 |
| Net Income per Employee | 64,179 |
| Average Collection Period | 51 |
| Receivables Turnover | 7.6 |
| Day's Inventory Turnover Ratio | 165 |
| Inventory Turnover | 2.2 |
| Inventory/Sales | 16.3 |
| Accounts Payble/Sales | 3.30 |
| Assets/Revenue | 0.63 |
| Net Working Capital Turnover | 2.70 |
| Fixed Assets Turnover | 4.20 |
| Total Assets Turnover | 1.6 |
| Revenue per $ Cash | 8.49 |
| Revenue per $ Plant | 15.75 |
| Revenue per $ Common Equity | 1.92 |
| Revenue per $ Capital Invested | 1.92 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 49.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 56.2 |
| Research & Devlopment (R&D) as % of Revenue | 10.3 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 10.3 |
|
|  
|
| |
 |  |